主页 实验库实验详情
E-GEOD-39976 GSE39976 transcription profiling by array Homo sapiens

Determination of molecular markers for BRCA1 and BRCA2 heterozygosity using gene expression profiling

·发布 2013年1月10日 ·更新 2014年6月2日
26
样本数
26
实验数
1
芯片平台
实验描述

Approximately 5% of all breast cancers can be attributed to an inherited mutation in one of two cancer susceptibility genes, BRCA1 and BRCA2. We searched for genes that have the potential to distinguish healthy BRCA1 and BRCA2 mutation carriers from non-carriers based on differences in expression profiling. Using expression microarrays we compared gene expression of irradiated lymphocytes from BRCA1 and BRCA2 mutation carriers versus control non-carriers. We identified 137 probe sets in BRCA1 carriers and 1345 in BRCA2 carriers with differential gene expression. Gene Ontology analysis revealed that most of these genes relate to regulation pathways of DNA repair processes, cell cycle regulation and apoptosis. Real-time PCR was performed on the 36 genes which were most prominently differentially expressed in the microarray assay; 21 genes were shown to be significantly differentially expressed in BRCA1 or BRCA2 mutation carriers as compared to controls (p<0.05). Based on a validation study with 40 mutation carriers and 17 non-carriers, a multiplex model that included six or more coincidental genes of 18 selected genes was constructed in order to predict the risk of carrying a mutation. The results using this model showed sensitivity 95% and specificity 88%. In summary, our study provides insight into the biological effect of heterozygous mutations in BRCA1 and BRCA2 genes in response to ionizing irradiation induced DNA damage. We also suggest a set of 18 genes that can be used as a prediction and screening tool for BRCA1 or BRCA2 mutational carriers by using easily obtained lymphocytes. Using expression microarrays we compared gene expression of irradiated lymphocytes from BRCA1 and BRCA2 mutation carriers versus control non-carriers Fresh blood samples were obtained from 9 BRCA1 and 8 BRCA2 mutation carriers and 9 mutation-negative women. Lymphocytes were collected from fresh blood samples, and RNA was extracted one hour after γ-irradiation

芯片平台
A-AFFY-37
Affymetrix GeneChip Human Genome U133A 2.0 [HG-U133A_2](26 例)
样本属性
mutation
BRCA1, BRCA2, non-carrier
Organism
Homo sapiens
organism part
lymphocytes
实验信息
登记号
E-GEOD-39976
GEO 编号
GSE39976
实验类型
transcription profiling by array
物种
Homo sapiens
发布日期
2013年1月10日
更新日期
2014年6月2日
提交者
Tamar Peretz、 tamar zahavi、 Asher Y Salmon、 Jasmine Jacob-Hirsch、 Mali Salmon-Divon、 Tamar Zahavi、 Yulia Barash
分析服务
分析服务

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com